{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:11:28Z","timestamp":1778350288462,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhongda Hospital Affiliated to Southeast University, Jiangsu Province High-Level Hospital Construction Funds","award":["2024GSPKY18"],"award-info":[{"award-number":["2024GSPKY18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13187-025-02668-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:44:57Z","timestamp":1751341497000},"page":"348-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Awareness, Attitudes, and Practice Related to Herpes Zoster and its Vaccines among Patients with Malignant Cancers: A Multi-Center Cross-Sectional Study in China"],"prefix":"10.1007","volume":"41","author":[{"given":"Pan","family":"Xiaoyuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Xinyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhengbang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"2668_CR1","unstructured":"Zheng RS, Chen R, Han BF et al (2024) Cancer incidence and mortality in China, 2022. Zhonghua Zhong Liu Za Zhi 46(3):221\u2013231"},{"issue":"4","key":"2668_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/CMR.00052-13","volume":"26","author":"AA Gershon","year":"2013","unstructured":"Gershon AA, Gershon MD (2013) Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev 26(4):728\u2013743","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"2668_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","volume":"39","author":"A Hata","year":"2011","unstructured":"Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537\u2013544","journal-title":"Infection"},{"issue":"11","key":"2668_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS (2007) A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction [published correction appears in Mayo Clin Proc. 2008 Feb;83(2):255]. Mayo Clin Proc 82(11):1341\u20131349","journal-title":"Mayo Clin Proc"},{"key":"2668_CR5","doi-asserted-by":"crossref","unstructured":"Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014;348:g2911. Published 2014 May 13.","DOI":"10.1136\/bmj.g2911"},{"issue":"2","key":"2668_CR6","doi-asserted-by":"publisher","first-page":"2228169","DOI":"10.1080\/21645515.2023.2228169","volume":"19","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Liu X, Suo L, Zhao D, Pan J, Lu L (2023) The incidence of herpes zoster in China: a meta-analysis and evidence quality assessment. Hum Vaccin Immunother 19(2):2228169","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"2668_CR7","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR et al (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352(22):2271\u20132284","journal-title":"N Engl J Med"},{"issue":"22","key":"2668_CR8","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O et al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372(22):2087\u20132096","journal-title":"N Engl J Med"},{"key":"2668_CR9","doi-asserted-by":"crossref","unstructured":"Izurieta HS, Wu X, Forshee R et al (2021) Recombinant zoster vaccine (Shingrix): real-world effectiveness in the first 2 years post-licensure. Clin Infect Dis 73(6):941\u2013948","DOI":"10.1093\/cid\/ciab125"},{"issue":"3","key":"2668_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","volume":"71","author":"TC Anderson","year":"2022","unstructured":"Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, Kotton CN, Dooling KL (2022) Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the advisory committee on immunization practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep 71(3):80\u201384","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2668_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1001\/jama.2010.1983","volume":"305","author":"HF Tseng","year":"2011","unstructured":"Tseng HF, Smith N, Harpaz R, Bialek SR, Sy LS, Jacobsen SJ (2011) Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA 305(2):160\u2013166","journal-title":"JAMA"},{"issue":"1","key":"2668_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.vaccine.2022.10.063","volume":"41","author":"KM Sullivan","year":"2023","unstructured":"Sullivan KM, Farraye FA, Winthrop KL, Willer DO, Vink P, Tavares-Da-Silva F (2023) Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine 41(1):36\u201348","journal-title":"Vaccine"},{"issue":"3","key":"2668_CR13","first-page":"307","volume":"27","author":"J Qiu","year":"2021","unstructured":"Qiu J, Sun XD, Hu JY et al (2021) Willingness to receive herpes zoster vaccine and factors influencing willingness among \u226550-year-old adults of Shanghai in May-June 2020. Chin J Vaccin Immun 27(3):307\u2013310, 329","journal-title":"Chin J Vaccin Immun"},{"issue":"6","key":"2668_CR14","first-page":"752","volume":"48","author":"SY Huang","year":"2022","unstructured":"Huang SY, Song JH, Xing LY (2022) Willingness and influencing factors of herpes zoster vaccination among residents\u226550 years old in Zhengzhou. South China J Prev Med 48(6):752\u2013755","journal-title":"South China J Prev Med"},{"issue":"1","key":"2668_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000240046","volume":"56","author":"E Paek","year":"2010","unstructured":"Paek E, Johnson R (2010) Public awareness and knowledge of herpes zoster:results of a global survey. Gerontology 56(1):20\u201331. https:\/\/doi.org\/10.1159\/000240046","journal-title":"Gerontology"},{"issue":"6","key":"2668_CR16","first-page":"899","volume":"44","author":"M Wang","year":"2023","unstructured":"Wang M, Long C, Hu MZ et al (2023) A study on knowledge, attitude, and vaccination behavior of herpes zoster vaccine among urban residents in selected areas of China. Chin J Epidemiol 44(6):899\u2013904","journal-title":"Chin J Epidemiol"},{"issue":"4","key":"2668_CR17","first-page":"365","volume":"23","author":"ACY Lam","year":"2017","unstructured":"Lam ACY, Chan MY, Chou HY et al (2017) A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting. Hong Kong Med J 23(4):365\u2013373","journal-title":"Hong Kong Med J"},{"issue":"5","key":"2668_CR18","doi-asserted-by":"publisher","first-page":"2073752","DOI":"10.1080\/21645515.2022.2073752","volume":"18","author":"T Al-Khalidi","year":"2022","unstructured":"Al-Khalidi T, Genidy R, Almutawa M et al (2022) Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: a cross-sectional study. Human Vaccin Immunother 18(5):2073752","journal-title":"Human Vaccin Immunother"},{"issue":"3","key":"2668_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/vaccines11030651","volume":"11","author":"D Al-Orini","year":"2023","unstructured":"Al-Orini D, Alshoshan AA, Almutiri AO et al (2023) Acceptability of herpes zoster vaccination among patients with diabetes: a cross-sectional study in Saudi Arabia. Vaccines (Basel) 11(3):651","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"2668_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","volume":"152","author":"LP Hurley","year":"2010","unstructured":"Hurley LP, Lindley MC, Harpaz R et al (2010) Barriers to the use of herpes zoster vaccine. Ann Intern Med 152(9):555\u2013560","journal-title":"Ann Intern Med"},{"key":"2668_CR21","doi-asserted-by":"crossref","unstructured":"Lu PJ, Hung MC, Srivastav A et al (2020) Shingles vaccination of U.S. adults aged 50-59 years and \u226560 years before recommendations for use of recombinant zoster vaccine. Am J Prev Med 59(1):21\u201331","DOI":"10.1016\/j.amepre.2020.01.017"},{"key":"2668_CR22","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1080\/21645515.2021.1960137","volume":"17","author":"X Lu","year":"2021","unstructured":"Lu X, Lu J, Zhang F, Wagner AL, Zhang L, Mei K, Guan B, Lu Y (2021) Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Hum Vaccines Immunother 17:4163\u20134170","journal-title":"Hum Vaccines Immunother"},{"key":"2668_CR23","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1016\/j.vaccine.2017.04.014","volume":"35","author":"R Eilers","year":"2017","unstructured":"Eilers R, De Melker HE, Veldwijk J, Krabbe PF (2017) Vaccine preferences and acceptance of older adults. Vaccine 35:2823\u20132830","journal-title":"Vaccine"},{"key":"2668_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24926\/iip.v3i2.257","volume":"3","author":"AB Coe","year":"2012","unstructured":"Coe AB, Gatewood SB, Moczygemba LR (2012) The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Innov Pharm 3:1","journal-title":"Innov Pharm"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-025-02668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-025-02668-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-025-02668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:01:51Z","timestamp":1778349711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-025-02668-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1007\/s13187-025-02668-1","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"6 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants in our study signed informed consent forms, ensuring the ethical integrity of our research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, a worldwide licence to the Publishers and its licensees in perpetuity, in all forms, formats and media (whether known now or created in the future), to i) publish, reproduce, distribute, display and store the Contribution, ii) translate the Contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and\/or, abstracts of the Contribution, iii) create any other derivative work(s) based on the Contribution, iv) to exploit all subsidiary rights in the Contribution, v) the inclusion of electronic links from the Contribution to third party material where-ever it may be located; and, vi) licence any third party to do any or all of the above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Copyright statement"}},{"value":"We have read and understood policy on declaration of interests and declare that we have no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}